189 related articles for article (PubMed ID: 35981899)
21. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.
Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X
J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267
[TBL] [Abstract][Full Text] [Related]
22. Comparison of integrin α
Dietz M; Dunet V; Mantziari S; Pomoni A; Dias Correia R; Testart Dardel N; Boughdad S; Nicod Lalonde M; Treglia G; Schafer M; Schaefer N; Prior JO
Eur J Hybrid Imaging; 2023 Feb; 7(1):3. PubMed ID: 36720731
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of 68 Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a head-to-head comparison with FDG-PET/CT.
Gondhane A; Verma P; Chandak A; Basu S
Nucl Med Commun; 2024 May; 45(5):412-419. PubMed ID: 38445350
[TBL] [Abstract][Full Text] [Related]
24. [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.
Haubner R; Finkenstedt A; Stegmayr A; Rangger C; Decristoforo C; Zoller H; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2005-13. PubMed ID: 27164900
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of a dual-receptor targeted tracer [
Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
[TBL] [Abstract][Full Text] [Related]
26. A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using
Lobeek D; Bouwman FCM; Aarntzen EHJG; Molkenboer-Kuenen JDM; Flucke UE; Nguyen HL; Vikkula M; Boon LM; Klein W; Laverman P; Oyen WJG; Boerman OC; Terry SYA; Schultze Kool LJ; Rijpkema M
J Nucl Med; 2020 Feb; 61(2):270-275. PubMed ID: 31519800
[TBL] [Abstract][Full Text] [Related]
27. A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of
Zhu W; Cheng Y; Jia R; Zhao H; Bai C; Xu J; Yao S; Huo L
J Nucl Med; 2021 Oct; 62(10):1398-1405. PubMed ID: 33579804
[No Abstract] [Full Text] [Related]
28. Head-to-Head Comparison of
Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
[No Abstract] [Full Text] [Related]
29. [
Bentsen S; Jensen JK; Christensen E; Petersen LR; Grandjean CE; Follin B; Madsen JS; Christensen C; Clemmensen A; Binderup T; Hasbak P; Ripa RS; Kjaer A
J Nucl Cardiol; 2023 Oct; 30(5):2073-2084. PubMed ID: 37127725
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Lung Cancer and Neuroendocrine Neoplasm in a Single Scan by Targeting Both Somatostatin Receptor and Integrin αvβ3.
Zheng Y; Wang H; Tan H; Cui X; Yao S; Zang J; Zhang L; Zhu Z
Clin Nucl Med; 2019 Sep; 44(9):687-694. PubMed ID: 31274560
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.
Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C
Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of
Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
[TBL] [Abstract][Full Text] [Related]
33. [
Zheng S; Chen Z; Huang C; Chen Y; Miao W
Ann Nucl Med; 2019 Feb; 33(2):135-143. PubMed ID: 30392070
[TBL] [Abstract][Full Text] [Related]
34. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Li ZB; Chen K; Chen X
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
[TBL] [Abstract][Full Text] [Related]
35. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
[TBL] [Abstract][Full Text] [Related]
36. Inter-heterogeneity and intra-heterogeneity of α
Kang F; Wang Z; Li G; Wang S; Liu D; Zhang M; Zhao M; Yang W; Wang J
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1520-1528. PubMed ID: 28405726
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of [
Jahandideh A; Ståhle M; Virta J; Li XG; Liljenbäck H; Moisio O; Knuuti J; Roivainen A; Saraste A
Front Med (Lausanne); 2021; 8():783596. PubMed ID: 34977085
[TBL] [Abstract][Full Text] [Related]
38. Application of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke.
Sun Y; Zeng Y; Zhu Y; Feng F; Xu W; Wu C; Xing B; Zhang W; Wu P; Cui L; Wang R; Li F; Chen X; Zhu Z
Theranostics; 2014; 4(8):778-86. PubMed ID: 24955139
[TBL] [Abstract][Full Text] [Related]
39. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
